Zhejiang Cancer Hospital

This study tests a combination of two drugs (Sac-TMT and a third-generation EGFR-TKI), with or without radiation, in 45 people with a specific type of advanced lung cancer (EGFR-mutated non-squamous NSCLC) that has spread to the brain and stopped responding to previous treatment.…

This early-phase trial tests whether umbilical cord blood cells can safely help people with chronic gut damage from past radiation therapy. Ten adults with moderate-to-severe symptoms will receive three weekly infusions of these cells. Researchers will check for side effects and …

This study tests whether a short course of radiation followed by the drug ivonescimab can shrink or eliminate rectal cancer in 30 adults with a specific genetic type (pMMR/MSS). Participants receive radiation for 5 days, then 6 cycles of ivonescimab. If the cancer disappears comp…

This early-stage study tests if cells from umbilical cord blood can safely help people with lung injury caused by chest radiation therapy. Ten adults aged 18-75 whose lung damage did not improve with standard care will receive the cell treatment. The goal is to see if it reduces …

This study will follow 500 women with epithelial ovarian, primary peritoneal, or fallopian tube cancer to see how safe and effective the drug senaparib is in real-world conditions. Participants will receive senaparib alone or with other treatments as decided by their doctor. The …

This study tests an oral form of the chemotherapy drug paclitaxel, taken daily or several times a week, for adults with advanced HER2-negative breast cancer. The trial has two parts: first, finding the safest dose of the oral paclitaxel alone, and then testing it combined with th…

This study follows 300 premenopausal women with early hormone-sensitive breast cancer to see how well they stick to ovarian suppression (OFS) hormone therapy and why some stop. Researchers will track treatment patterns, side effects, and long-term outcomes over several years. The…